-transparent.png){kind=logo}
Epstein-Barr virus (EBV) can be maintained in lymphoblastoid cell lines. The infection is usually latent and the lack of a fully permissive cell have made the studies of the lytic functions of the virus difficult. In these cell lines virus production can be induced by addition of phorbol esters, n-butyrate, or nucleotide analogues. These compounds have been used to study EBV in several aspects: the latent and lytic functions of EBV. The possible use of this model system as an in vitro assay for tumor promoters. The mechanism behind the tumor promoter and n-butyrate induced activation of EBV.
Related Publications
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
February 1979,
Proceedings of the National Academy of Sciences of the United States of America,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
January 1982,
Cancer letters,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
March 1983,
Proceedings of the National Academy of Sciences of the United States of America,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
January 2010,
Biochimica et biophysica acta,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
January 1983,
The EMBO journal,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
April 1984,
International journal of cancer,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
December 1986,
AIDS research,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
February 1980,
Virology,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
November 2008,
Nature medicine,
L Eliasson, and
M T Nilsson, and
B Kallin, and
G Klein
September 2010,
PLoS pathogens,
